AP1638A - Peptide mimics of conserved gonococcal epitopes and methods and compositions using them. - Google Patents

Peptide mimics of conserved gonococcal epitopes and methods and compositions using them.

Info

Publication number
AP1638A
AP1638A APAP/P/2002/002511A AP2002002511A AP1638A AP 1638 A AP1638 A AP 1638A AP 2002002511 A AP2002002511 A AP 2002002511A AP 1638 A AP1638 A AP 1638A
Authority
AP
ARIPO
Prior art keywords
compositions
methods
peptide mimics
epitopes
conserved
Prior art date
Application number
APAP/P/2002/002511A
Other versions
AP2002002511A0 (en
Inventor
Peter A Rice
Jutamas Ngampasutadol
Sunita Gulati
Original Assignee
Peter A Rice
Jutamas Ngampasutadol
Sunita Gulati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter A Rice, Jutamas Ngampasutadol, Sunita Gulati filed Critical Peter A Rice
Publication of AP2002002511A0 publication Critical patent/AP2002002511A0/en
Application granted granted Critical
Publication of AP1638A publication Critical patent/AP1638A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to peptide mimics of conserved gonoccocal epitode of Neisseria gonorrhoeae, which epitope is not found on human blood group antigens. This invention also relates to methods and compositions using such peptide mimics for the prophylaxis of gonorrheal infections.
APAP/P/2002/002511A 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them. AP1638A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16249199P 1999-10-29 1999-10-29
PCT/US2000/029749 WO2001032692A2 (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them

Publications (2)

Publication Number Publication Date
AP2002002511A0 AP2002002511A0 (en) 2002-06-30
AP1638A true AP1638A (en) 2006-07-20

Family

ID=22585848

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002511A AP1638A (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them.

Country Status (6)

Country Link
CN (2) CN101638433B (en)
AP (1) AP1638A (en)
AU (1) AU785022B2 (en)
NZ (2) NZ518915A (en)
OA (1) OA12315A (en)
WO (1) WO2001032692A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101899097B (en) * 2010-07-07 2012-02-01 南方医科大学 A kind of B blood group antigen epitope mimetic peptide and its application
CN101899096B (en) * 2010-07-07 2012-07-04 南方医科大学 Blood group A epitope mimic peptide and application thereof
CN115003324A (en) * 2019-09-23 2022-09-02 马萨诸塞大学 Polyantigenic peptide mimetics of gonococcal Lipooligosaccharide (LOS) epitopes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022479A1 (en) * 1993-04-06 1994-10-13 Trustees Of Health & Hospitals Of The City Of Boston Gonococcal anti-idiotypic antibodies and methods and compositions using them
WO1999040189A2 (en) * 1998-02-09 1999-08-12 Genset Cdnas encoding secreted proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022479A1 (en) * 1993-04-06 1994-10-13 Trustees Of Health & Hospitals Of The City Of Boston Gonococcal anti-idiotypic antibodies and methods and compositions using them
WO1999040189A2 (en) * 1998-02-09 1999-08-12 Genset Cdnas encoding secreted proteins

Also Published As

Publication number Publication date
WO2001032692A3 (en) 2002-03-07
NZ518915A (en) 2004-05-28
AU1242001A (en) 2001-05-14
AU785022B2 (en) 2006-08-24
AP2002002511A0 (en) 2002-06-30
WO2001032692A2 (en) 2001-05-10
CN1409725A (en) 2003-04-09
CN101638433B (en) 2014-10-29
OA12315A (en) 2006-05-15
HK1141034A1 (en) 2010-10-29
CN101638433A (en) 2010-02-03
NZ532271A (en) 2006-03-31
CN1409725B (en) 2012-06-06

Similar Documents

Publication Publication Date Title
NO20022531L (en) Vaccine for the prevention and treatment of Alzheimer's and amyloid-related diseases
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
MY144612A (en) Nogo-a neutralising immunoglobulins for treatment of neurological diseases
HUP9802212A2 (en) Recombinant anti-cd4 antibodies for human therapy
EP1194164B8 (en) Prion protein peptides and uses thereof
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2004024068A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
NZ324500A (en) Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
SG173214A1 (en) Immunological methods and compositions for the treatment of alzhemier's disease
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
IL201889A (en) Therapeutic compositions for the treatment of immune related disorders comprising antibodies that specifically recognize the nk 1.1 antigen or the cd56 antigen expressed by nk t cells
NO20081124L (en) Anti-CD 3 antibody formulations
EP2322200A3 (en) Compositions and methods for the treatment of immune related diseases
ATE233814T1 (en) HUMAN NEUTRALIZING MONOCLONAL ANTIBODY AGAINST THE VIRUS THAT CAUSES HUMAN IMMUNE DEFICIENCY
ZA200501054B (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use.
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
AU2002310474A1 (en) Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
ES2054484T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIGEN-ANTIBODY COMPLEXES, AS WELL AS THE USE OF THE SAME.
WO2003059260A3 (en) Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease